Literature DB >> 12869417

Simultaneous generation of multiple mitochondrial DNA mutations in human prostate tumors suggests mitochondrial hyper-mutagenesis.

Junjian Z Chen1, Neriman Gokden, Graham F Greene, Bridgett Green, Fred F Kadlubar.   

Abstract

Multiple somatic mitochondrial DNA mutations are frequently reported in human tumors, but the process leading to homoplasmic transformation and accumulation of multiple mutations in the same tumor cell lineage remains a mystery. We address possible mechanisms responsible for the generation of multiple mitochondrial (mt)DNA mutations observed in a high frequency of prostate tumors using sensitive mutant-specific PCR coupled with laser capture microdissection. Analysis of prostate tumors with multiple mtDNA mutations in the control region indicates that the mutations are locally confined, that the multiple mutations exist on the same molecules and that more than one mtDNA mutant species co-exists in the same neoplastic lesion. These results suggest an unusually rapid process in mtDNA mutagenesis during tumor progression. On the basis of prostate tumor cell kinetics, we propose a unique process of mitochondrial hyper-mutagenesis, probably mediated by cellular oxidative stress, to account for a burst of multiple mtDNA mutations in human prostate tumors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12869417     DOI: 10.1093/carcin/bgg102

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  17 in total

Review 1.  Altered metabolism and mitochondrial genome in prostate cancer.

Authors:  G D Dakubo; R L Parr; L C Costello; R B Franklin; R E Thayer
Journal:  J Clin Pathol       Date:  2006-01       Impact factor: 3.411

2.  Detection of novel mitochondrial mutations in cytochrome C oxidase subunit 1 (COX1) in patients with familial adenomatous polyposis (FAP).

Authors:  E Afkhami; M M Heidari; M Khatami; F Ghadamyari; S Dianatpour
Journal:  Clin Transl Oncol       Date:  2019-09-24       Impact factor: 3.405

3.  Somatic mitochondrial DNA mutations in prostate cancer and normal appearing adjacent glands in comparison to age-matched prostate samples without malignant histology.

Authors:  Ryan L Parr; Gabriel D Dakubo; Keith A Crandall; Jennifer Maki; Brian Reguly; Andrea Aguirre; Roy Wittock; Kerry Robinson; Jude S Alexander; Mark A Birch-Machin; Mamdouh Abdel-Malak; M Kent Froberg; Eleftherios P Diamandis; Robert E Thayer
Journal:  J Mol Diagn       Date:  2006-07       Impact factor: 5.568

Review 4.  Mitochondrial-nuclear epistasis: implications for human aging and longevity.

Authors:  Gregory J Tranah
Journal:  Ageing Res Rev       Date:  2010-06-25       Impact factor: 10.895

5.  3.4 kb mitochondrial genome deletion serves as a surrogate predictive biomarker for prostate cancer in histopathologically benign biopsy cores.

Authors:  Brian Reguly; John P Jakupciak; Ryan L Parr
Journal:  Can Urol Assoc J       Date:  2010-10       Impact factor: 1.862

6.  Pathological Roles of Reactive Oxygen Species in Male Reproduction.

Authors:  Saptaparna Chakraborty; Shubhadeep Roychoudhury
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 7.  Oxidative stress in prostate cancer.

Authors:  Lakshmipathi Khandrika; Binod Kumar; Sweaty Koul; Paul Maroni; Hari K Koul
Journal:  Cancer Lett       Date:  2009-01-30       Impact factor: 8.679

Review 8.  Implications of mitochondrial DNA mutations and mitochondrial dysfunction in tumorigenesis.

Authors:  Jianxin Lu; Lokendra Kumar Sharma; Yidong Bai
Journal:  Cell Res       Date:  2009-07       Impact factor: 25.617

Review 9.  Oxidative stress induces mitochondrial DNA damage and cytotoxicity through independent mechanisms in human cancer cells.

Authors:  Yue Han; Junjian Z Chen
Journal:  Biomed Res Int       Date:  2012-12-26       Impact factor: 3.411

10.  Simultaneous quantification of mitochondrial DNA damage and copy number in circulating blood: a sensitive approach to systemic oxidative stress.

Authors:  Sam W Chan; Simone Chevalier; Armen Aprikian; Junjian Z Chen
Journal:  Biomed Res Int       Date:  2012-12-27       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.